tOPV

Recent forum posts

Guidance Note: How to handle and dispose of tOPV found after 1 May 2016

Next steps in Polio Endgame Strategy: the switch from tOPV to bOPV

Visit the Forum

From the Knowledge Hub

Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial

Author: Ricardo Rüttimann, Ananda S. Bandyopadhyay, Steve Self, Luis Rivera, Xavier Saez-Llorens, Eduardo López, Mario Melgar, James T. Gaensbauer, William C. Weldon, Steven Oberste, Bhavesh R. Borate, Chris Gast, Ralf Clemens, Walter Orenstein, Miguel O'Ryan G. , José Jimeno , Sue Ann Costa Clemens , Joel Ward, Edwin J Asturias

Interference of Monovalent, Bivalent, and Trivalent Oral Poliovirus Vaccines on Monovalent Rotavirus Vaccine Immunogenicity in Rural Bangladesh

Author: Khalequ Zaman, Abhijeet Anand, Umesh Parashar, Baoming Jiang, Ben Lopman, Concepción F Estívariz, Daniel E. Velasquez, Devy M. Emperador

Regulatory aspects of Sabin Type 2 withdrawal from trivalent Oral Poliovirus Vaccine: Process and lessons learned

Author: Roland Sutter, Razieh Ostad Ali Dehaghi, Marina Takane, Jacqueline Fournier-Caruana, Daniela Decina

Systematization of the Introduction of IPV and Switch from tOPV to bOPV in the Americas

Author: Cristina Pedreira, Barbara Jauregui, Elizabeth Thrush

Health and economic consequences of different options for timing the coordinated global cessation of the three oral poliovirus vaccine serotypes

Author: Radboud J. Duintjer Tebbens, Kimberly M. Thompson

Browse the Knowledge Hub

Careers

No careers found.

Partner news

No Blog entries found.

TechNet webinars

COM_KHUB_PANEL_WEBINARS_EMPTY

Browse Webinars

Hot Topics

No Hot Topics found.

View all Hot Topics

Upcoming events

No upcoming events.

By vaccine

Recent forum posts

From the Knowledge Hub

Careers

Partner news

TechNet webinars

Hot Topics

Upcoming events

About

Knowledge Hub

Community

More